IN
Innovage Holding Corp.
INNV · NASDAQ
$10.92 +1.87% (+$0.20)
1M +0.94%
Market Cap $1.48B
P/E Ratio -
Div. Yield -
ROE 1.05%
Bulios Fair Price
$10.04
8.1% downside
Current Price
$10.92
Undervalued Fair Value Overvalued
According to Bulios Fair Price, INNV is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
40 /100
Fair P/S 1.50x
P/B 6.21x
P/FCF 20.48x
Growth
42 /100
Stable Book val. growth 10.92%
Rev. growth 6.91%
FCF growth N/A
Profitability
21 /100
Weak Net margin 0.26%
Op. margin 0.26%
FCF margin 7.31%
Quality
16 /100
Poor ROE 1.05%
ROA 0.46%
Asset turnover 1.78x
Debt
71 /100
Low Current ratio 1.05x
Int. coverage -2.26x
Net debt/EBITDA -2.50x
Stability
43 /100
Moderate Rev. volatility 7.46%
EPS volatility 294.35%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about INNV
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Patrick Blair
Employees
2,500
Headquarters
Denver
Upcoming events
03 NOV
Earnings
Upcoming earnings report